We’re excited to announce the latest webinar in our Leadership Lens series! Episode 2, The Evolving GLP-1 Landscape, drops Tuesday, August 12. Join us for a deep dive into the GLP-1 landscape and how it may impact your plan and members. This episode features insights from top experts at Gateway Health Partners and VytlOne: A. Azim Bari, PharmD, MBA, BCPS, Ian Parnigoni PharmD, Angie Oster, Pharm.D., and Paul Fischer PharmD. Stay tuned to our channel on Tuesday for the recorded webinar’s premiere!
About us
With its nearly 100 years of Pharmacy Rxpertise, VytlOne (formerly Maxor) is the nation’s only independent, fully integrated total pharmacy solutions partner. With its innovative model of customized pharmacy management, 340B program expertise, specialty pharmacy, and PBA or PBM solutions, VytlOne is leading the way in unlocking revenue, growth and better outcomes for mission-driven hospitals, health systems, health centers, and employer partners. VytlOne’s independent model ensures custom solutions, working alongside you and your mission to unlock your pharmacy’s full financial potential—and drive Rxtraordinary revenue. In 2024 alone, VytlOne delivered $1.3 billion in revenue back to our partners. Backed by nearly a century of deep-rooted expertise, VytlOne champions hospitals, health systems, and healthcare organizations to achieve unmatched patient outcomes and build healthier healthcare communities. We help ensure more of your revenue stays local, directly fueling vital investments. By acting as an extension of your team, VytlOne champions your mission and goals with tailored expertise, innovative strategies, and Rxceptional service so that you can go from good to great. Great to Rxtraordinary. At VytlOne, Your Mission Is Our Mission — a commitment that drives everything we do. It’s what sets us apart from the competition and fuels our passion to help healthcare organizations and employer providers thrive while delivering the best care and solutions to their patients and employees. Partner with VytlOne and experience the difference that true integration, independence, and dedication bring to your pharmacy solutions.
- Website
-
http://www.maxor.com
External link for VytlOne
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Plano, Texas
- Type
- Privately Held
- Specialties
- Healthcare, Pharmacy, Pharmacy Benefit Management, Correctional Pharmacy, Pharmacy Management, Pharmacy Consulting, 340B Pharmacy Operations, Pharmacy Technology, Mail Order Pharmacy, Specialty Pharmacy, Home Infusion Pharmacy, Specialty Pharmacy Management, and Pharmacy Strategy
Locations
-
Primary
Get directions
2805 Dallas Pkwy
500
Plano, Texas 75093, US
-
Get directions
320 S Polk St
200
Amarillo, Texas 79101, US
Employees at VytlOne
Updates
-
Are you ready for an improved standard of care? Introducing RxCare, our innovate care platform that integrates pharmacists into the patient care team. RxCare pharmacists provide personalized medication management, conduct through medication reviews, and offer expert advice on drug interactions and side effects. This helps you reduce drug interactions, identify barriers to adherence, and increase patient satisfaction. Learn more today: https://lnkd.in/gW6puQ8u
-
On July 31, the Food and Drug Administration announced new labeling requirements for opioid medications. Labels should include the following: 1. Clearer risk information 2. Dosing warnings 3. Clarified use limits 4. Treatment guidance 5. Safe discontinuation 6. Overdose reversal agents 7. Drug interactions 8. More risks with overdose 9. Digestive health To see the full statement, please visit https://lnkd.in/gZ-k5bx7
-
-
What is a VytlOne Liaison? A Liaison is a pharmacy employee dedicated to supporting patients and providers. Liaisons: · Assist with prior authorizations · Provide patient education · Help patients identify and apply for financial assistance · Request patient refills from providers · Identify and notify providers of adherence issues · Operate patient management programs required for ACHC specialty accreditation Liaisons can make a significant impact on your patients’ experience and satisfaction as well as your pharmacy’s bottom line. Watch below to learn how a local health department implemented and benefits from the VytlOne Liaison program.
-
It’s time for our monthly New Drug Spotlight! Several new drugs received FDA approval in mid-2025, addressing diverse medical conditions. This month, we’re spotlight 3 new drugs to market: one for bladder cancer, one for multiple myeloma, and one for hereditary angioedema. Scroll below to learn more about each drug and its impact. For more drug approvals and pipeline analysis, don’t forget to read our new Drug Pipeline Report Q3 2025: https://lnkd.in/gS2WScqZ
-
As biosimilar options expand, so do the complexities of formulary management. In our third clip from episode one of our Leadership Lens webinar, we explore how staying ahead of pipeline changes, helps patients have access to cost-effective, clinically appropriate therapies. Watch the full webinar featuring VytlOne’s Paul Fischer PharmD and Gateway Health Partners’ Scott Webb and A. Azim Bari, PharmD, MBA, BCPS here: https://lnkd.in/gvVhAEn3 Want to learn more about biosimilar formulary management support? Email our team at pafischer@vytlone.com
-
In the ever-evolving world of healthcare, long-acting injectable drugs (commonly known as LAIs) are making significant waves. These medicines, administered through injections, are designed to release their active ingredients slowly and steadily into the bloodstream over days or even weeks. LAIs are already transforming the way we treat mental health disorders and a variety of other chronic conditions. Check out our latest blog where we explore the benefits and challenges of LAIs in modern medicine: https://lnkd.in/g6csmrr8
-
-
Today is World Hepatitis Day. According to the World Health Organization (WHO), hepatitis is an inflammation of the liver caused by various infectious viruses and noninfectious agents. Hepatitis can lead to serious health problems and can even be fatal. There are five main types of hepatitis: A, B, C, D, and E. Hepatitis B is the most common form. Statistics from 2022 from WHO indicate that globally: · About 254 million people have chronic hepatitis B. · About 50 million people have chronic hepatitis C. To learn more about hepatitis, please visit https://lnkd.in/gwFE_2qE
-
-
Are you curious how some medicines, once available only by prescription, end up on your local pharmacy shelves for anyone to purchase? The U.S. Food and Drug Administration (FDA) has a well-defined process for this transformation, known as the Prescription-to-Nonprescription (RX-to-OTC) switch. In our latest blog, we explore the process and spotlight five notable drugs that have made the leap from prescription-only to over-the-counter (OTC) availability. Read now: https://lnkd.in/gzHWnwP3
-